eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

Interview with Professor Janusz Skowronek
ABS 2015
5/2018
vol. 10
 
Share:
Share:
more
 
 
abstract:
Original paper

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model

Thomas Brun, Gwenael Ferron, Thomas Filleron, Jacques Bonnet, Alejandra Martinez, Anne Ducassou, Fabien Corbiere, Martine Delannes

J Contemp Brachytherapy 2018; 10, 5: 463–469
Online publish date: 2018/10/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
The aim of this study is to investigate the feasibility of perioperative I-125 low-dose-rate brachytherapy mesh implantation in pelvic locations in an animal model, before applying it clinically.

Material and methods
The animal model was the Romanov adult ewe. Non-radioactive dummy I-125 seeds were implanted by laparotomy in the pelvic area. Forty-five dummy seeds were placed on a 10 cm² polyglactin mesh to obtain a dose of 160 Gy at 5 mm from the center of each seed. Three CT scans were performed at day 15, day 70, and day 180 after surgery to check the positioning of the mesh for eventual seed migration according to bony landmarks and to perform a 3D theoretical dosimetric study. The experimental study design was based on Simon’s minimax plan with a preliminary analysis of 10 ewes to validate the protocol and a second series of 7 ewes.

Results
After the first step, 9 of 10 ewes were investigated. For 8 of 9 animals, the 160 Gy isodose line volume was within 10%, showing feasibility of the procedure and allowing 7 more to be added. At the end of the study, 16 of 17 animals were examined. No seeds loss was observed. The volume difference of the 160 Gy isodose line was within 10% in 13 of 16 ewes between the three CT scans. Twelve out of 16 had a coordinate deviation less than or equal to 10 mm on the three axes between the first and the third scans.

Conclusions
These results show the technical feasibility of the pelvic mesh implantation in ewes. A phase I study for patients with locally advanced or recurrent pelvic tumors amenable to surgery, in combination with surgical resection should be possible.

keywords:

I-125 seeds, animal model, brachytherapy, pelvic location

references:
Krengli M, Pisani C, Deantonio L et al. Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder, and prostate cancers. Radiat Oncol 2017; 12: 18.
Llewelyn M, Taylor A. Re-irradiation of cervical and endometrial cancer. Curr Opin Oncol 2017; 29: 343-350.
Backes FJ, Billingsley CC, Martin DD et al. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer? Gynecol Oncol 2014; 135: 95-99.
Calvo F, Sole C, Lozano M et al. Gynecologic Oncology Intraoperative electron beam radiotherapy and extended surgical resection for gynecological pelvic recurrent malignancies with and without external beam radiation therapy: Long-term outcomes. Gynecol Oncol 2013; 130: 537-544.
Nath R, Bice WS, Butler WM et al. AAPM Recommendations on Dose Prescription and Reporting Methods for Permanent Interstitial Brachytherapy for Prostate Cancer: Report of AAPM Task Group No 137, 2009.
Nath R, Anderson LL, Luxton G et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No 43. Med Phys 1995; 22: 209-234.
Nath R, Dewerd LA, Dezarn WA et al. Guidelines by the AAPM and GEC-ESTRO on the use of innovative brachytherapy devices and applications: Report of Task Group No 167. Med Phys 2016; 43: 3178-3205.
Pisters BPWT, Harrison LB, Woodruff JM et al. Tissue sarcomas of the extremity and superficial trunk. J Clin Oncol 1994; 12: 1150-1155.
Lla C, Delannes M, Minsat M et al. Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structure. Radiother Oncol 2006; 78: 10-16.
Muhic A, Hovgaard D, Mørk M et al. Local control and survival in patients with soft tissue sarcomas treated with limb sparing surgery in combination with interstitial brachytherapy and external radiation. Radiother Oncol 2008; 88: 382-387.
San Miguel I, San Julian M, Cambeiro M et al. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam. Int J Radiat Oncol Biol Phys 2011; 81: 529-539.
Holloway CL, Delaney TF, Alektiar KM et al. American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy. Brachytherapy 2013; 12: 179-190.
Lloyd S, Alektiar KM, Nag S et al. Intraoperative high-dose-rate brachytherapy: An American Brachytherapy Society consensus report. Brachytherapy 2017; 16: 446-465.
D’Amato T, Galloway M, Szydlowski G et al. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest 1998; 114: 1112-1115.
Voynov G, Heron DE, Lin CJ et al. Intraoperative 125 I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy 2005; 4: 278-285.
Chen A, Galloway M, Landreneau R et al. Intraoperative I125 brachytherapy for high-risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 1999; 44: 1057-1063.
Fernando HC, Santos RS, Benfield JR et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005; 129: 261-267.
Santos R, Colonias A, Parda D et al. Comparison between sublobar resection and 125 Iodine brachytherapy after sublobar resection in high-risk patients with stage I non-small-cell lung cancer. Surgery 2003; 134: 691-697.
Mutyala S, Stewart A, Khan AJ et al. Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. Int J Radiat Oncol Biol Phys 2010; 76: 1114-1120.
Fairweather M, Wang J, Devlin PM et al. Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol 2014; 22: 1455-1463.
Ferré M, Mailleux H, Pierrat N, Dejean C. Brachytherapy dose calculation. Cancer Radiother 2013; 17: 89-92.
Beaulieu L, Tedgren A, Carrier JF et al. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: Current status and recommendations for clinical implementation. Med Phys 2012; 39: 6208-6236.
Leblanc E, Narducci F, Bresson L et al. A new laparoscopic method of bowel radio-protection before pelvic chemoradiation of locally advanced cervix cancers. Surg Endosc 2014; 28: 2713-2718.
Choi HJ, Lee HS. Effect of omental pedicle hammock in protection against radiation-induced enteropathy in patients with rectal cancer. Dis Colon Rectum 1995; 38: 276-280.
Lechner P, Cesnik H. Abdominopelvic omentopexy: preparatory procedure for radiotherapy in rectal cancer. Dis Colon Rectum 1992; 35: 1157-1160.
Uehara S, Oue T, Adachi K et al. Tissue expander placement to prevent the adverse intestinal effects of radiotherapy in malignant pelvic tumors. J Pediatr Hematol Oncol 2016; 38: 78-81.
 
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe